Biodribin® – side effects

Łukasiewicz Research Network – Industrial Chemistry Institute, pursuant to the provisions of the Pharmaceutical Law, is obliged to continuously monitor adverse reactions caused by the use of its medicinal products by collecting information on adverse reactions and forwarding it to the appropriate competent authorities.

NOTE! The following communication channels are not intended to provide medical advice and/or information. In such matters, please contact your doctor or pharmacist.

Please report suspected adverse reactions to the contact details below:

Monday – Friday 8:00 a.m. – 4:00 p.m.

phone +48 660 775 526
piotr.zaleski@ichp.lukasiewicz.gov.pl

24/7

phone + 48 604 44 66 58
iba@sciencepharma.pl

At the same time, we would like to inform you that adverse reactions can be reported directly to the Department of Monitoring Adverse Drug Reactions of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:

Al. Jerozolimskie 181C
02-222 Warsaw, Poland
phone +48 22 492 13 01
fax +48 22 492 13 09

Webside: https://smz.ezdrowie.gov.pl